Loading…
Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl‐2 suppression in Epstein‐Barr virus (EBV)‐transformed B‐lymphoblastoid cells, but not in EBV‐positive natural killer cell lymphoma cells
Epstein‐Barr virus (EBV)‐encoded latent membrane protein 1 (LMP‐1) is essential for immortalization of B cells by EBV, protects the infected cells from apoptotic cell death and induces Bcl‐2 expression. Suppression of LMP‐1 expression by antisense oligodeoxynucleotides (AS‐oligo) to LMP‐1 inhibits p...
Saved in:
Published in: | British journal of haematology 2001-07, Vol.114 (1), p.84-92 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3 |
container_end_page | 92 |
container_issue | 1 |
container_start_page | 84 |
container_title | British journal of haematology |
container_volume | 114 |
creator | Noguchi, Toshio Ikeda, Kazuma Yamamoto, Kazuhiko Yoshida, Isao Ashiba, Atsuko Tsuchiyama, Junjiro Shinagawa, Katsuji Yoshino, Tadashi Takata, Minoru Harada, Mine |
description | Epstein‐Barr virus (EBV)‐encoded latent membrane protein 1 (LMP‐1) is essential for immortalization of B cells by EBV, protects the infected cells from apoptotic cell death and induces Bcl‐2 expression. Suppression of LMP‐1 expression by antisense oligodeoxynucleotides (AS‐oligo) to LMP‐1 inhibits proliferation, promotes apoptosis and suppresses Bcl‐2 expression in EBV‐transformed B cells. However, the function of LMP‐1 expression in EBV‐positive natural killer (NK) cell lymphoma cells has not been reported previously. We examined the function of LMP‐1 in two EBV‐positive NK cell lymphoma cell lines (NK‐YS and YT) through suppressing LMP‐1 expression by AS‐oligo to LMP‐1. The AS‐oligo to LMP‐1 suppressed LMP‐1 mRNA and protein expression in two EBV‐positive NK cell lymphoma cell lines, as well as in an EBV‐transformed B‐cell line (CMG‐1). Proliferation was inhibited, apoptosis was induced and Bcl‐2 expression was suppressed in CMG‐1 cells, but none of these events were observed in NK‐YS or YT cells. These results suggest that proliferation, inhibition of apoptosis and Bcl‐2 expression in EBV‐positive NK cell lymphoma cells are not directly regulated by LMP‐1 as in EBV‐transformed B‐cell lines, but are probably mediated through other signal transducing systems. |
doi_str_mv | 10.1046/j.1365-2141.2001.02887.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71037209</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71037209</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3</originalsourceid><addsrcrecordid>eNqNkc9uEzEQxlcIREPhFZAvIJCaYK-d3eyBQ1MFCqrEBXq1bO9s4-BdLx5vm9x4hD5jX4ML3iSiV07-M7_vm9F8WUYYnTEqig-bGePFfJozwWY5pWxG88WinG2fZJN_hafZhFJaTpNgcZK9QNwkkNM5e56dMCbKnItqkv0576JF6BCId_bG1-C3u24wDny0NSCJnjgVoYukhVYH1QHpg49gO8KI7erBALkJ_i6u02tttY3Wd2dE9b6PHi0S1dVkadzD7_uc4ND3ARATkmiy6nE0SqWlCoHc2jAgebdaXr9PXzH1wsaHFpI-vd2u7ddeO4XR25oYcA7PiB4i6Xzcuy2vE9anptHeAulUHIJy5Kd1DsKeJwePVh3UL7NnjXIIr47nafbj0-r7xeX06tvnLxfnV1MjSlFOtdBa5UqbolJ1NeeFaeqiKgUUJmdcC16URcMrBXOgvK4EMG1qoysGhSgbA_w0e3vwTYv7NQBG2VocJ0jL9APKklFe5rRK4OIAmuARAzSyD7ZVYScZlWPwciPHfOWYrxyDl_vg5TZJXx97DDpt7FF4TDoBb46AQqNck7ZrLD5yghZlJXjiPh64O-tg998DyOXXy_HG_wJ0a9Xl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71037209</pqid></control><display><type>article</type><title>Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl‐2 suppression in Epstein‐Barr virus (EBV)‐transformed B‐lymphoblastoid cells, but not in EBV‐positive natural killer cell lymphoma cells</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Noguchi, Toshio ; Ikeda, Kazuma ; Yamamoto, Kazuhiko ; Yoshida, Isao ; Ashiba, Atsuko ; Tsuchiyama, Junjiro ; Shinagawa, Katsuji ; Yoshino, Tadashi ; Takata, Minoru ; Harada, Mine</creator><creatorcontrib>Noguchi, Toshio ; Ikeda, Kazuma ; Yamamoto, Kazuhiko ; Yoshida, Isao ; Ashiba, Atsuko ; Tsuchiyama, Junjiro ; Shinagawa, Katsuji ; Yoshino, Tadashi ; Takata, Minoru ; Harada, Mine</creatorcontrib><description>Epstein‐Barr virus (EBV)‐encoded latent membrane protein 1 (LMP‐1) is essential for immortalization of B cells by EBV, protects the infected cells from apoptotic cell death and induces Bcl‐2 expression. Suppression of LMP‐1 expression by antisense oligodeoxynucleotides (AS‐oligo) to LMP‐1 inhibits proliferation, promotes apoptosis and suppresses Bcl‐2 expression in EBV‐transformed B cells. However, the function of LMP‐1 expression in EBV‐positive natural killer (NK) cell lymphoma cells has not been reported previously. We examined the function of LMP‐1 in two EBV‐positive NK cell lymphoma cell lines (NK‐YS and YT) through suppressing LMP‐1 expression by AS‐oligo to LMP‐1. The AS‐oligo to LMP‐1 suppressed LMP‐1 mRNA and protein expression in two EBV‐positive NK cell lymphoma cell lines, as well as in an EBV‐transformed B‐cell line (CMG‐1). Proliferation was inhibited, apoptosis was induced and Bcl‐2 expression was suppressed in CMG‐1 cells, but none of these events were observed in NK‐YS or YT cells. These results suggest that proliferation, inhibition of apoptosis and Bcl‐2 expression in EBV‐positive NK cell lymphoma cells are not directly regulated by LMP‐1 as in EBV‐transformed B‐cell lines, but are probably mediated through other signal transducing systems.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1046/j.1365-2141.2001.02887.x</identifier><identifier>PMID: 11472349</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adaptor Proteins, Signal Transducing ; antisense oligodeoxynucleotides ; apoptosis ; Apoptosis - drug effects ; Biological and medical sciences ; Blotting, Western ; Carrier Proteins - genetics ; Cell Division - drug effects ; Cell Line, Transformed ; Cytoskeletal Proteins ; EBV‐positive NK‐cell lymphoma ; Gene Deletion ; Gene Expression - drug effects ; Hematologic and hematopoietic diseases ; Herpesvirus 4, Human ; Humans ; Intracellular Signaling Peptides and Proteins ; Killer Cells, Natural - metabolism ; Killer Cells, Natural - virology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; LIM Domain Proteins ; LMP‐1 ; Lymphoma, T-Cell - metabolism ; Lymphoma, T-Cell - virology ; Medical sciences ; Oligonucleotides, Antisense - pharmacology ; proliferation ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Tumor Cells, Cultured</subject><ispartof>British journal of haematology, 2001-07, Vol.114 (1), p.84-92</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3</citedby><cites>FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14067943$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11472349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Noguchi, Toshio</creatorcontrib><creatorcontrib>Ikeda, Kazuma</creatorcontrib><creatorcontrib>Yamamoto, Kazuhiko</creatorcontrib><creatorcontrib>Yoshida, Isao</creatorcontrib><creatorcontrib>Ashiba, Atsuko</creatorcontrib><creatorcontrib>Tsuchiyama, Junjiro</creatorcontrib><creatorcontrib>Shinagawa, Katsuji</creatorcontrib><creatorcontrib>Yoshino, Tadashi</creatorcontrib><creatorcontrib>Takata, Minoru</creatorcontrib><creatorcontrib>Harada, Mine</creatorcontrib><title>Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl‐2 suppression in Epstein‐Barr virus (EBV)‐transformed B‐lymphoblastoid cells, but not in EBV‐positive natural killer cell lymphoma cells</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Epstein‐Barr virus (EBV)‐encoded latent membrane protein 1 (LMP‐1) is essential for immortalization of B cells by EBV, protects the infected cells from apoptotic cell death and induces Bcl‐2 expression. Suppression of LMP‐1 expression by antisense oligodeoxynucleotides (AS‐oligo) to LMP‐1 inhibits proliferation, promotes apoptosis and suppresses Bcl‐2 expression in EBV‐transformed B cells. However, the function of LMP‐1 expression in EBV‐positive natural killer (NK) cell lymphoma cells has not been reported previously. We examined the function of LMP‐1 in two EBV‐positive NK cell lymphoma cell lines (NK‐YS and YT) through suppressing LMP‐1 expression by AS‐oligo to LMP‐1. The AS‐oligo to LMP‐1 suppressed LMP‐1 mRNA and protein expression in two EBV‐positive NK cell lymphoma cell lines, as well as in an EBV‐transformed B‐cell line (CMG‐1). Proliferation was inhibited, apoptosis was induced and Bcl‐2 expression was suppressed in CMG‐1 cells, but none of these events were observed in NK‐YS or YT cells. These results suggest that proliferation, inhibition of apoptosis and Bcl‐2 expression in EBV‐positive NK cell lymphoma cells are not directly regulated by LMP‐1 as in EBV‐transformed B‐cell lines, but are probably mediated through other signal transducing systems.</description><subject>Adaptor Proteins, Signal Transducing</subject><subject>antisense oligodeoxynucleotides</subject><subject>apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Carrier Proteins - genetics</subject><subject>Cell Division - drug effects</subject><subject>Cell Line, Transformed</subject><subject>Cytoskeletal Proteins</subject><subject>EBV‐positive NK‐cell lymphoma</subject><subject>Gene Deletion</subject><subject>Gene Expression - drug effects</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Herpesvirus 4, Human</subject><subject>Humans</subject><subject>Intracellular Signaling Peptides and Proteins</subject><subject>Killer Cells, Natural - metabolism</subject><subject>Killer Cells, Natural - virology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>LIM Domain Proteins</subject><subject>LMP‐1</subject><subject>Lymphoma, T-Cell - metabolism</subject><subject>Lymphoma, T-Cell - virology</subject><subject>Medical sciences</subject><subject>Oligonucleotides, Antisense - pharmacology</subject><subject>proliferation</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Tumor Cells, Cultured</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqNkc9uEzEQxlcIREPhFZAvIJCaYK-d3eyBQ1MFCqrEBXq1bO9s4-BdLx5vm9x4hD5jX4ML3iSiV07-M7_vm9F8WUYYnTEqig-bGePFfJozwWY5pWxG88WinG2fZJN_hafZhFJaTpNgcZK9QNwkkNM5e56dMCbKnItqkv0576JF6BCId_bG1-C3u24wDny0NSCJnjgVoYukhVYH1QHpg49gO8KI7erBALkJ_i6u02tttY3Wd2dE9b6PHi0S1dVkadzD7_uc4ND3ARATkmiy6nE0SqWlCoHc2jAgebdaXr9PXzH1wsaHFpI-vd2u7ddeO4XR25oYcA7PiB4i6Xzcuy2vE9anptHeAulUHIJy5Kd1DsKeJwePVh3UL7NnjXIIr47nafbj0-r7xeX06tvnLxfnV1MjSlFOtdBa5UqbolJ1NeeFaeqiKgUUJmdcC16URcMrBXOgvK4EMG1qoysGhSgbA_w0e3vwTYv7NQBG2VocJ0jL9APKklFe5rRK4OIAmuARAzSyD7ZVYScZlWPwciPHfOWYrxyDl_vg5TZJXx97DDpt7FF4TDoBb46AQqNck7ZrLD5yghZlJXjiPh64O-tg998DyOXXy_HG_wJ0a9Xl</recordid><startdate>200107</startdate><enddate>200107</enddate><creator>Noguchi, Toshio</creator><creator>Ikeda, Kazuma</creator><creator>Yamamoto, Kazuhiko</creator><creator>Yoshida, Isao</creator><creator>Ashiba, Atsuko</creator><creator>Tsuchiyama, Junjiro</creator><creator>Shinagawa, Katsuji</creator><creator>Yoshino, Tadashi</creator><creator>Takata, Minoru</creator><creator>Harada, Mine</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200107</creationdate><title>Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl‐2 suppression in Epstein‐Barr virus (EBV)‐transformed B‐lymphoblastoid cells, but not in EBV‐positive natural killer cell lymphoma cells</title><author>Noguchi, Toshio ; Ikeda, Kazuma ; Yamamoto, Kazuhiko ; Yoshida, Isao ; Ashiba, Atsuko ; Tsuchiyama, Junjiro ; Shinagawa, Katsuji ; Yoshino, Tadashi ; Takata, Minoru ; Harada, Mine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adaptor Proteins, Signal Transducing</topic><topic>antisense oligodeoxynucleotides</topic><topic>apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Carrier Proteins - genetics</topic><topic>Cell Division - drug effects</topic><topic>Cell Line, Transformed</topic><topic>Cytoskeletal Proteins</topic><topic>EBV‐positive NK‐cell lymphoma</topic><topic>Gene Deletion</topic><topic>Gene Expression - drug effects</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Herpesvirus 4, Human</topic><topic>Humans</topic><topic>Intracellular Signaling Peptides and Proteins</topic><topic>Killer Cells, Natural - metabolism</topic><topic>Killer Cells, Natural - virology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>LIM Domain Proteins</topic><topic>LMP‐1</topic><topic>Lymphoma, T-Cell - metabolism</topic><topic>Lymphoma, T-Cell - virology</topic><topic>Medical sciences</topic><topic>Oligonucleotides, Antisense - pharmacology</topic><topic>proliferation</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Noguchi, Toshio</creatorcontrib><creatorcontrib>Ikeda, Kazuma</creatorcontrib><creatorcontrib>Yamamoto, Kazuhiko</creatorcontrib><creatorcontrib>Yoshida, Isao</creatorcontrib><creatorcontrib>Ashiba, Atsuko</creatorcontrib><creatorcontrib>Tsuchiyama, Junjiro</creatorcontrib><creatorcontrib>Shinagawa, Katsuji</creatorcontrib><creatorcontrib>Yoshino, Tadashi</creatorcontrib><creatorcontrib>Takata, Minoru</creatorcontrib><creatorcontrib>Harada, Mine</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Noguchi, Toshio</au><au>Ikeda, Kazuma</au><au>Yamamoto, Kazuhiko</au><au>Yoshida, Isao</au><au>Ashiba, Atsuko</au><au>Tsuchiyama, Junjiro</au><au>Shinagawa, Katsuji</au><au>Yoshino, Tadashi</au><au>Takata, Minoru</au><au>Harada, Mine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl‐2 suppression in Epstein‐Barr virus (EBV)‐transformed B‐lymphoblastoid cells, but not in EBV‐positive natural killer cell lymphoma cells</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2001-07</date><risdate>2001</risdate><volume>114</volume><issue>1</issue><spage>84</spage><epage>92</epage><pages>84-92</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><abstract>Epstein‐Barr virus (EBV)‐encoded latent membrane protein 1 (LMP‐1) is essential for immortalization of B cells by EBV, protects the infected cells from apoptotic cell death and induces Bcl‐2 expression. Suppression of LMP‐1 expression by antisense oligodeoxynucleotides (AS‐oligo) to LMP‐1 inhibits proliferation, promotes apoptosis and suppresses Bcl‐2 expression in EBV‐transformed B cells. However, the function of LMP‐1 expression in EBV‐positive natural killer (NK) cell lymphoma cells has not been reported previously. We examined the function of LMP‐1 in two EBV‐positive NK cell lymphoma cell lines (NK‐YS and YT) through suppressing LMP‐1 expression by AS‐oligo to LMP‐1. The AS‐oligo to LMP‐1 suppressed LMP‐1 mRNA and protein expression in two EBV‐positive NK cell lymphoma cell lines, as well as in an EBV‐transformed B‐cell line (CMG‐1). Proliferation was inhibited, apoptosis was induced and Bcl‐2 expression was suppressed in CMG‐1 cells, but none of these events were observed in NK‐YS or YT cells. These results suggest that proliferation, inhibition of apoptosis and Bcl‐2 expression in EBV‐positive NK cell lymphoma cells are not directly regulated by LMP‐1 as in EBV‐transformed B‐cell lines, but are probably mediated through other signal transducing systems.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>11472349</pmid><doi>10.1046/j.1365-2141.2001.02887.x</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1048 |
ispartof | British journal of haematology, 2001-07, Vol.114 (1), p.84-92 |
issn | 0007-1048 1365-2141 |
language | eng |
recordid | cdi_proquest_miscellaneous_71037209 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Adaptor Proteins, Signal Transducing antisense oligodeoxynucleotides apoptosis Apoptosis - drug effects Biological and medical sciences Blotting, Western Carrier Proteins - genetics Cell Division - drug effects Cell Line, Transformed Cytoskeletal Proteins EBV‐positive NK‐cell lymphoma Gene Deletion Gene Expression - drug effects Hematologic and hematopoietic diseases Herpesvirus 4, Human Humans Intracellular Signaling Peptides and Proteins Killer Cells, Natural - metabolism Killer Cells, Natural - virology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis LIM Domain Proteins LMP‐1 Lymphoma, T-Cell - metabolism Lymphoma, T-Cell - virology Medical sciences Oligonucleotides, Antisense - pharmacology proliferation Proto-Oncogene Proteins c-bcl-2 - genetics Reverse Transcriptase Polymerase Chain Reaction Tumor Cells, Cultured |
title | Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl‐2 suppression in Epstein‐Barr virus (EBV)‐transformed B‐lymphoblastoid cells, but not in EBV‐positive natural killer cell lymphoma cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A01%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antisense%20oligodeoxynucleotides%20to%20latent%20membrane%20protein%201%20induce%20growth%20inhibition,%20apoptosis%20and%20Bcl%E2%80%902%20suppression%20in%20Epstein%E2%80%90Barr%20virus%20(EBV)%E2%80%90transformed%20B%E2%80%90lymphoblastoid%20cells,%20but%20not%20in%20EBV%E2%80%90positive%20natural%20killer%20cell%20lymphoma%20cells&rft.jtitle=British%20journal%20of%20haematology&rft.au=Noguchi,%20Toshio&rft.date=2001-07&rft.volume=114&rft.issue=1&rft.spage=84&rft.epage=92&rft.pages=84-92&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1046/j.1365-2141.2001.02887.x&rft_dat=%3Cproquest_cross%3E71037209%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71037209&rft_id=info:pmid/11472349&rfr_iscdi=true |